Results 151 to 160 of about 9,294,018 (384)

The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead

Advanced Biology, EarlyView.
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi, Anjali Kumari, Samaneh Ghadami, Saqer Al Abdullah, Kristen Dellinger   +4 more
wiley   +1 more source

Insights and recommendations for working collaboratively and improving care in Alzheimer's disease: Learnings from the Finding Alzheimer's Solutions Together (F.A.S.T.) Council

Health Expectations
Background Collaborations between patient organisations (POs) and the pharmaceutical industry can help identify and address the unmet needs of people living with a disease.
Jannice Roeser, Nikki Bayliss, Marco Blom, Ruth Croney, Lydia Lanman, Jerson Laks, Marco Lyons, Lea Proulx, Marianna Tsatali, Karin Westerlund, Jean Georges   +10 more
doaj   +1 more source

Nursing Home Chain Affiliation and Its Impact on Specialty Service Designation for Alzheimer Disease

Inquiry: The Journal of Health Care Organization, Provision, and Financing, 2018
Specialty care units (SCUs) in nursing homes (NHs) grew in popularity during the 1990s to attract residents while national policies and treatment paradigms changed. Alzheimer disease has consistently been the dominant form of SCU. This study explored the
Justin Blackburn PhD, Qing Zheng MA, David C. Grabowski PhD, Richard Hirth PhD, Orna Intrator PhD, David G. Stevenson PhD, Jane Banaszak-Holl PhD   +6 more
doaj   +1 more source

A Comprehensive Comparison Between ANNs and KANs For Classifying EEG Alzheimer's Data [PDF]

arXiv
Alzheimer's Disease is an incurable cognitive condition that affects thousands of people globally. While some diagnostic methods exist for Alzheimer's Disease, many of these methods cannot detect Alzheimer's in its earlier stages. Recently, researchers have explored the use of Electroencephalogram (EEG) technology for diagnosing Alzheimer's.
arxiv  

Alzheimer disease

Nature Reviews Disease Primers, 2021
D. Knopman, H. Amièva, R. Petersen, G. Chételat, D. Holtzman, B. Hyman, R. Nixon, David T. Jones   +7 more
semanticscholar   +1 more source

Chiral Engineered Biomaterials: New Frontiers in Cellular Fate Regulation for Regenerative Medicine

Advanced Functional Materials, EarlyView.
Chiral engineered biomaterials can selectively influence cell behaviors in regenerative medicine. This review covers chiral engineered biomaterials in terms of their fabrication methods, cellular response mechanisms, and applications in directing stem cell differentiation and tissue function.
Yuwen Wang, Xin Zhang, Denghui Xie, Chunying Chen, Zhifeng Huang, Zhong Alan Li   +5 more
wiley   +1 more source

3D Inception-based CNN with sMRI and MD-DTI data fusion for Alzheimer's Disease diagnostics [PDF]

arXiv, 2018
In the last decade, computer-aided early diagnostics of Alzheimer's Disease (AD) and its prodromal form, Mild Cognitive Impairment (MCI), has been the subject of extensive research. Some recent studies have shown promising results in the AD and MCI determination using structural and functional Magnetic Resonance Imaging (sMRI, fMRI), Positron Emission ...
arxiv  

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. [PDF]

, 1993
Kazumitsu Ueda, Hideto Fukushima, Eliezer Masliah, Yu Xia, Akihiko Iwai, Makoto Yoshimoto, D A Otero, J. Kondo, Yasuo Ihara, T Saitoh   +9 more
openalex   +1 more source

Alleviation of Aging‐Related Hallmarks in a Mouse Model of Progeria via a Nanoparticle‐Based Artificial Transcription Factor

Advanced Functional Materials, EarlyView.
Oct4‐nanoscript, a biomimetic nanoparticle‐based artificial transcription factor, precisely regulates cellular rejuvenation by activating Oct4 target genes, restoring epigenetic marks, and reducing DNA damage. In a progeria model, it effectively rescued aging‐associated pathologies and extended lifespan.
Hongwon Kim, Junyeop Kim, Euiyeon Lee, Brandon Conklin, Yannan Hou, Sumin Kim, Yerim Hwang, Ki‐Bum Lee, Jongpil Kim   +8 more
wiley   +1 more source

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. [PDF]

, 1993
D. E. Schmechel, Ann M. Saunders, Warren J. Strittmatter, Barbara J. Crain, Christine M. Hulette, Sun Hyung Joo, Margaret A. Pericak‐Vance, Dmitry Goldgaber, Allen D. Roses   +8 more
openalex   +1 more source